Illumina, Inc. (NASDAQ:ILMN) today announced that the Company will webcast its presentations at two upcoming investment conferences in September 2008.
Illumina will webcast its presentation at the Thomas Weisel Health Care Conference in Boston, Massachusetts on September 4, 2008. The live webcast is scheduled to begin at 3:50 p.m. ET. Illumina will also webcast its presentation at the UBS Global Life Sciences Conference in New York, New York on September 23, 2008. The live webcast is scheduled to begin at 8:00 a.m. ET. Both conferences will feature an overview of Illumina by Christian Henry, Senior Vice President and Chief Financial Officer, followed by a question and answer session.
Both live webcasts can be accessed under the "Corporate/Investor Information" tab of Illumina's web site at www.illumina.com.
About Illumina
Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the large-scale analysis of genetic variation and biological function. Using our proprietary technologies, we provide a comprehensive line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and we expect to enter the market for molecular diagnostics. Our customers include leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Our tools provide researchers around the world with the performance, throughput, cost effectiveness, and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery and clinical research, allow diseases to be detected earlier, and permit better choices of drugs for individual patients. |
